GAMMA Investing’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$179K Buy
1,799
+216
+14% +$19.8K 0.01% 1414
2026
Q2
$152K Sell
1,583
-163
-9% -$14.9K 0.01% 1490
2026
Q1
$64.7K Buy
1,746
+176
+11% +$5.63K ﹤0.01% 2000
2025
Q4
$31.7K Buy
1,570
+104
+7% +$2.52K ﹤0.01% 2356
2025
Q3
$44.1K Buy
1,466
+222
+18% +$4.81K ﹤0.01% 2077
2025
Q2
$16.1K Buy
1,244
+273
+28% +$2.6K ﹤0.01% 2571
2025
Q1
$7.08K Buy
971
+589
+154% +$6.51K ﹤0.01% 2916
2024
Q4
$6.35K Sell
382
-28
-7% -$373 ﹤0.01% 2815
2024
Q3
$5.27K Buy
410
+391
+2,058% +$5.65K ﹤0.01% 2724
2024
Q2
$212 Sell
19
-3
-14% -$35 ﹤0.01% 3327
2024
Q1
$273 Buy
+22
New +$367 ﹤0.01% 3195

Other funds holding AEHR

GAMMA Investing's AEHR Position: Q3 2026 in Review

GAMMA Investing increased its Aehr Test Systems (AEHR) stake by 14% in Q3 2026, buying an estimated $19.8K and bringing the position to 1,799 shares worth $179K. The position accounts for 0.01% of the portfolio, ranked #1414.

GAMMA Investing first reported a position in AEHR in Q1 2024 and has held it in 11 quarters since. 52 funds tracked by Wall St. Rank hold AEHR as of Q3 2026.

  • GAMMA Investing held 1,799 shares of Aehr Test Systems worth $179K as of Q3 2026.
  • GAMMA Investing bought 216 Aehr Test Systems shares in Q3 2026, an estimated $19.8K.
  • Aehr Test Systems made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #1414 holding.
  • GAMMA Investing first reported a position in Aehr Test Systems in Q1 2024 and has held it in 11 quarters since.
  • 52 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.